Biotechnology • Inflammatory
Bambusa Therapeutics is a biotechnology company developing transformative treatments for inflammatory and immunological conditions.
Biotechnology • Clinical-stage
Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing novel treatments for serious musculoskeletal diseases.
Epigenetic editing • Genetic medicines
nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.
Biopharmaceutical • Clinical-stage
Maze Therapeutics is a biopharmaceutical company focused on developing precision medicines for renal and metabolic diseases using human genetics.
Radiopharmaceuticals • Clinical-stage
Alpha-9 Oncology Inc. develops targeted radiopharmaceuticals to improve cancer treatment.
Biotechnology • Clinical-stage
Aktis Oncology is a clinical-stage biotechnology company developing a proprietary radiopharmaceutical pipeline, including Nectin-4-targeted miniprotein radioconjugates, for cancer treatment.
Single Cell Sequencing • Life Sciences
Parse Biosciences is a company that develops and commercializes scalable single-cell sequencing technologies for use in over 1,000 labs globally, aiming to expand its product range and market presence with its recent $50 million funding.